Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It’s our ‘crown jewel’

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly…
Read More

Reviews

0 %

User Score

0 ratings
Rate This

Sharing

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments